Company intelligence

SABS

SAB Biotherapeutics, Inc. · NASDAQ · Healthcare

Price$2.60+2.77% · +$0.07

Market cap236.56MEquity value

P / E-2.0Trailing ratio

Volume602.33KLatest session

Market data

SABS price chart

TradingView

Related signals

1 min delayed

Browse public SABS signals with their source context and measured market impact. Open any signal for its permanent analysis page.

SABSJan 28, 2025+7.73% since signal

Why Is SAB BIO Stock Trading Lower On Tuesday?

SAB BIO's SAB-142 met primary safety objectives for Phase 1 trial. SAB-142 shows favorable safety profile and sustained immunomodulation. Phase 2b trial for SAB-142 planned for 2025 in type 1 diabetes. Current SABS stock price down 50.2% to $2.17 at last check.

View signal analysis

Research